Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic Model

• প্রধান লেখক: Jacinda C. Abdul-Mutakabbir (লেখক), Razieh Kebriaei (লেখক), Kyle C. Stamper (লেখক), Zain Sheikh (লেখক), Philip T. Maassen (লেখক), Katherine L. Lev (লেখক), Michael J. Rybak (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2020-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

The most efficacious antimicrobial therapy to aid in the successful elimination of resistant <i>S. aureus</i> infections is unknown. In this study, we evaluated varying phenotypes of <i>S. aureus</i> against dalbavancin (DAL), vancomycin (VAN), and daptomycin (DAP) alone and...